| 2016 |
FBXW11 serves as the F-box substrate recognition subunit of the SCF(FBXW11) E3 ubiquitin ligase complex that mediates proteasomal degradation of PKR (protein kinase R) during Rift Valley fever virus (RVFV) infection. The viral NSs protein recruits PKR to the SCF(FBXW11) complex by binding FBXW11 via a six-amino-acid degron sequence (DDGFVE) and recruiting PKR through an alternate binding site. siRNA knockdown of FBXW11 or MLN4924 treatment blocked PKR degradation, activating PKR and suppressing RVFV replication. |
siRNA knockdown, small-molecule inhibitor (MLN4924), degron mutant viruses, co-immunoprecipitation |
PLoS pathogens |
High |
26837067 27122577
|
| 2016 |
Both FBXW11 and β-TRCP1 (FBXW1) F-box proteins are required for full NSs-mediated PKR degradation; maximal PKR protection required simultaneous knockdown of both paralogs. NSs was found to interact with both FBXW11 and β-TRCP1. |
siRNA screen of ~70 human F-box proteins, co-immunoprecipitation, PKR phosphorylation assays |
Journal of virology |
Medium |
27122577
|
| 2014 |
SCF(FBXW11) binds, polyubiquitylates, and destabilizes RAPGEF2 (a RAP1 guanine nucleotide exchange factor). Substrate trapping proteomics identified 21 known and 23 novel candidate substrates for FBXW11. |
PAC (parallel adapter capture) substrate-trapping proteomics with proteasome inhibition, mass spectrometry, immunopurification, ubiquitination assay |
Molecular and cellular biology |
Medium |
25332235
|
| 2019 |
De novo missense variants in FBXW11 clustering at the surface loops of the substrate-binding WD40 domain cause diverse developmental anomalies in humans. Structural analyses predicted destabilization of the protein and/or its substrate interactions. Knockdown of zebrafish fbxw11a and fbxw11b orthologs produced smaller/misshapen eyes and abnormal jaw and pectoral fin development, consistent with roles in Wnt (β-catenin) and Hh (GLI) signaling during development. |
Whole exome/genome sequencing, structural modeling, in situ hybridization, zebrafish morpholino knockdown |
American journal of human genetics |
Medium |
31402090
|
| 2021 |
FBXW11 physically interacts with ASK1 (apoptosis signal-regulating kinase 1) and promotes its ubiquitination, leading to aberrant activation of NF-κB and MAPK signaling pathways in microglial cells. Hippocampus-specific knockout of FBXW11 reduced Aβ plaque load, neuronal death, and microglial activation in Alzheimer's disease mouse models through restraint of ASK1/MAPKs/NF-κB signaling. |
Co-immunoprecipitation, ubiquitination assay, siRNA knockdown, hippocampus-specific knockout mouse model, immunofluorescence |
Biochemical and biophysical research communications |
Medium |
33640602
|
| 2021 |
FBXW11 targets HIC1 (hypermethylated in cancer 1) for ubiquitination and proteasomal degradation in colorectal cancer cells. Loss of HIC1 leads to upregulation of SIRT1 transcription, promoting stem-cell-like features and liver metastasis. |
Co-immunoprecipitation, ubiquitination assay, siRNA/shRNA knockdown, xenograft mouse models |
Cell death & disease |
Medium |
34642302
|
| 2025 |
FBXW11 mechanistically promotes HIC1 ubiquitination and proteasomal degradation in pancreatic acinar cells during acute pancreatitis. This releases IRF1 from transcriptional suppression by HIC1, increasing inflammatory cytokine production (IL-6, TNF-α, IL-1β). Silencing FBXW11 reduced inflammation and apoptosis in vitro and in vivo. |
Co-immunoprecipitation, ubiquitination assay, chromatin immunoprecipitation (ChIP), murine cerulein AP model, RNA-seq |
Digestive diseases and sciences |
Medium |
41288880
|
| 2024 |
FBXW11 ubiquitinates IL-17RA through K27-linked polyubiquitin chains, targeting it for proteasomal degradation. The domain spanning residues 665–804 of IL-17RA is critical for interaction with FBXW11 and subsequent ubiquitination. |
Co-immunoprecipitation, ubiquitination assay, domain mapping, bioinformatics |
Biomedicines |
Medium |
38672111
|
| 2025 |
FBXW11 directly interacts with the cold shock domain (CSD) of YB1 and promotes K48-linked polyubiquitination and proteasomal degradation of YB1 in hepatocellular carcinoma, thereby suppressing the YB1/Akt/mTOR signaling pathway and inhibiting tumor growth. |
Co-immunoprecipitation, mass spectrometry, ubiquitination assay, xenograft mouse models, rescue experiments with YB1 re-expression |
Journal of cancer research and clinical oncology |
Medium |
40944757
|
| 2025 |
FBXW11 targets S100A11 for ubiquitination-mediated proteasomal degradation in ovarian cancer cells. Increased S100A11 degradation leads to less efficient DNA damage repair, sensitizing cells to PARP inhibitors. |
4D label-free quantitative proteomics, ubiquitination assay, siRNA/overexpression, xenograft mouse models |
Journal of pharmaceutical analysis |
Medium |
40747341
|
| 2025 |
A recurrent FBXW11 missense mutation (p.F517S) found in salivary basal cell adenomas causes defective binding to β-catenin, resulting in higher nuclear β-catenin levels and activation of the Wnt/β-catenin pathway. This mutation is mutually exclusive with CTNNB1 gain-of-function mutations, establishing FBXW11-mediated β-catenin binding/degradation as the canonical tumor suppressive mechanism. |
Next-generation sequencing of tumor cohort, in vitro binding assays for β-catenin interaction, immunofluorescence for nuclear β-catenin, mutual exclusivity analysis |
Nature communications |
Medium |
40389436
|
| 2025 |
circMAN1A2 competes with FBXW11 for binding to SFPQ, preventing FBXW11-mediated K48-linked ubiquitination and proteasomal degradation of SFPQ, thereby stabilizing SFPQ expression in gastric cancer cells. |
Co-immunoprecipitation, mass spectrometry, ubiquitination assay, RNA pull-down |
Journal of experimental & clinical cancer research |
Medium |
39856764
|
| 2018 |
Fbxw11 overexpression in lymphocytic leukemia cells promotes cell proliferation and cell cycle progression through concomitant activation of NF-κB and β-catenin/TCF signaling pathways, as demonstrated by reporter gene assays and blocking experiments. |
Cell proliferation assays, reporter gene assays, pathway blocking experiments, xenograft tumor formation in vivo |
Cell death & disease |
Low |
29555946
|